Fekrvand S - Search Results

1

Brain-to-brain interface technology: A brief history, current state, and future goals.

Vakilipour P, Fekrvand S. Vakilipour P, et al. Among authors: fekrvand s. Int J Dev Neurosci. 2024 May 6. doi: 10.1002/jdn.10334. Online ahead of print. Int J Dev Neurosci. 2024. PMID: 38711277

2

Clinical heterogeneity in families with multiple cases of inborn errors of immunity.

Delavari S, Rasouli SE, Fekrvand S, Chavoshzade Z, Mahdaviani SA, Shirmast P, Sharafian S, Sherkat R, Momen T, Aleyasin S, Ahanchian H, Sadeghi-Shabestari M, Esmaeilzadeh H, Barzamini S, Tarighatmonfared F, Salehi H, Esmaeili M, Marzani Z, Fathi N, Abolnezhadian F, Rad MK, Saeedi-Boroujeni A, Shirkani A, Bagheri Z, Salami F, Shad TM, Marzbali MY, Mojtahedi H, Razavi A, Tavakolinia N, Cheraghi T, Tavakol M, Shafiei A, Behniafard N, Ebrahimi SS, Sepahi N, Ghaneimoghadam A, Rezaei A, Kalantari A, Abolhassani H, Rezaei N. Delavari S, et al. Among authors: fekrvand s. Clin Immunol. 2024 Feb;259:109896. doi: 10.1016/j.clim.2024.109896. Epub 2024 Jan 4. Clin Immunol. 2024. PMID: 38184287

3

The Evaluation of Hematological Parameters and Their Correlation with Disease Prognosis in COVID-19 Disease in Iran.

Shahi F, Safaee Nodehi SR, Fekrvand S, Fathi F, Dabiri MR, Abdollahi A, Hosseini H. Shahi F, et al. Among authors: fekrvand s. Int J Hematol Oncol Stem Cell Res. 2023 Apr 1;17(2):89-99. doi: 10.18502/ijhoscr.v17i2.12645. Int J Hematol Oncol Stem Cell Res. 2023. PMID: 37637772 Free PMC article.

4

Neuronal nitric oxide synthase inhibition accelerated the removal of fluoxetine's anxiogenic activity in an animal model of PTSD.

Sadeghi MA, Hemmati S, Yousefi-Manesh H, Fekrvand S, Foroutani L, Nassireslami E, Yousefi Zoshk M, Hosseini Y, Dehpour AR, Chamanara M. Sadeghi MA, et al. Among authors: fekrvand s. Behav Brain Res. 2023 Feb 2;437:114128. doi: 10.1016/j.bbr.2022.114128. Epub 2022 Sep 26. Behav Brain Res. 2023. PMID: 36174841

5

B- and T-Cell Subset Abnormalities in Monogenic Common Variable Immunodeficiency.

Fekrvand S, Khanmohammadi S, Abolhassani H, Yazdani R. Fekrvand S, et al. Front Immunol. 2022 Jun 15;13:912826. doi: 10.3389/fimmu.2022.912826. eCollection 2022. Front Immunol. 2022. PMID: 35784324 Free PMC article. Review.

6

Role of rare immune cells in common variable immunodeficiency.

Soltani M, Rezaei M, Fekrvand S, Ganjalikhani-Hakemi M, Abolhassani H, Yazdani R. Soltani M, et al. Among authors: fekrvand s. Pediatr Allergy Immunol. 2022 Feb;33(2):e13725. doi: 10.1111/pai.13725. Pediatr Allergy Immunol. 2022. PMID: 34937129 Review.

7

Increased Expression of B Lymphocyte Induced Maturation Protein 1 (BLIMP1) in Patients with Common Variable Immunodeficiency (CVID).

Farrokhi S, Abbasi-Rad F, Esmaeil N, Sherkat R, Yazdani R, Afshar-Ghasemlou S, Fekrvand S, Ganjalikhani-Hakemi M. Farrokhi S, et al. Among authors: fekrvand s. Iran J Allergy Asthma Immunol. 2020 Aug 25;19(4):437-446. doi: 10.18502/ijaai.v19i4.4118. Iran J Allergy Asthma Immunol. 2020. PMID: 33463110 Free article.

8

The First Case Report of Kabuki Syndrome from the National Iranian Registry of Primary Immunodeficiencies.

Safarirad M, Ganji AA, Fekrvand S, Yazdani R, Motlagh AV, Abolhassani H, Aghamohammadi A. Safarirad M, et al. Among authors: fekrvand s. Endocr Metab Immune Disord Drug Targets. 2021;21(11):2099-2103. doi: 10.2174/1871530321666210114153920. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 33459250

9

The First Iranian Cohort of Pediatric Patients with Activated Phosphoinositide 3-Kinase-δ (PI3Kδ) Syndrome (APDS).

Fekrvand S, Delavari S, Chavoshzadeh Z, Sherkat R, Mahdaviani SA, Sadeghi Shabestari M, Azizi G, Arzanian MT, Shahin Shamsian B, Eskandarzadeh S, Eslami N, Rae W, Condino-Neto A, Mohammadi J, Abolhassani H, Yazdani R, Aghamohammadi A. Fekrvand S, et al. Immunol Invest. 2022 Apr;51(3):644-659. doi: 10.1080/08820139.2020.1863982. Epub 2021 Jan 6. Immunol Invest. 2022. PMID: 33401995

10

Evaluation of Expression of LRBA and CTLA-4 Proteins in Common Variable Immunodeficiency Patients.

Salami F, Fekrvand S, Yazdani R, Shahkarami S, Azizi G, Bagheri Y, Delavari S, Shariati S, Mahdaviani SA, Nabavi M, Shirkani A, Abolhassani H, Samadi M, Aghamohammadi A. Salami F, et al. Among authors: fekrvand s. Immunol Invest. 2022 Feb;51(2):381-394. doi: 10.1080/08820139.2020.1833029. Epub 2020 Nov 15. Immunol Invest. 2022. PMID: 33191838

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page